Sutro Biopharma, Inc. (NASDAQ: STRO ) specializes in antibody-drug conjugates [ADCs] for oncology therapeutics. The company leverages its proprietary XpressCF and XpressCF+ platforms to produce complex proteins without using living cells. This gives STRO more control over protein synthesis and site-specific drug My name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science f ...